KLK3 and prostate carcinoma: Our study of 868 men with raised PSA (3-10ng/mL) and histologically-confirmed prostate cancer has demonstrated that genetically correcting PSA for the combined genetic effect of four PSA-SNPs, did not improve upon the traditional single PSA threshold for biopsy when distinguishing high and low risk disease.